semaglutide loss of exclusivity Over $13 billion in U.S. drug sales are losing patent protection in 2026. But payers shouldn't expect cost relief soon. --- Billions in biologic sales are losing patent protection this year, but… The $300B Erosion Problem: How

Your smoothing partner in crime

If you want to understand what these medications actually do and how they work, see our full guide to what is GLP-1

Following the consultation, our medical professionals will assess your current health, BMI, and weight loss goals to decide if Semaglutide fits you well

Monitor your blood sugar levels during treatment and let your provider know if you get low readings

But the brand-name versions made by a handful of pharmaceutical companies can be pricey, with Novo Nordisk's Wegovy costing about $1,350 a month, or more than $16,00 a year, without insurance, according to GoodRx

I argue that the question is no longer should kids take these drugs? The GLP-1 experiment in kids is already well underway